by inpharmedia | Feb 9, 2025 | Blog, Guidances
Introduction Obesity has become one of the most pressing public health concerns worldwide, with significant implications for individual health and healthcare systems. As a result, the need for effective weight reduction therapies has never been more critical. To... by inpharmedia | Jan 24, 2024 | Guidances, Regulatory
FDA published a new guidance in support of Drug Competition Action Plan, named “Revising ANDA Labeling Following Revision of the RLD Labeling”, providing the recommendations to tentatively approved ANDAs to help facilitate final approval on the earliest lawful...